Works matching DE "AFATINIB"

Results: 187
    1
    2
    3
    4

    The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

    Published in:
    Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
    By:
    • Chang, Allison E B;
    • Piper-Vallillo, Andrew J;
    • Mak, Raymond H;
    • Lanuti, Michael;
    • Muzikansky, Alona;
    • Rotow, Julia;
    • Jänne, Pasi A;
    • Mino-Kenudson, Mari;
    • Swanson, Scott;
    • Wright, Cameron D;
    • Kozono, David;
    • Marcoux, Paul;
    • Piotrowska, Zofia;
    • Sequist, Lecia V;
    • Willers, Henning
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non--Small Cell Lung Cancer: Updated Analysis of the RESET Study.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1152, doi. 10.4143/crt.2023.493
    By:
    • Taeyun Kim;
    • Tae Won Jang;
    • Chang Min Choi;
    • Mi-Hyun Kim;
    • Sung Yong Lee;
    • Yoon Soo Chang;
    • Kye Young Lee;
    • Seung Joon Kim;
    • Sei Hoon Yang;
    • Jeong Seon Ryu;
    • Jeong Eun Lee;
    • Shin Yup Lee;
    • Chan Kwon Park;
    • Sang Hoon Lee;
    • Seung Hun Jang;
    • Seong Hoon Yoon;
    • Hyung-Joo Oh
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 17, p. 5809, doi. 10.1002/cam4.4127
    By:
    • Kim, Taeyun;
    • Jang, Tae Won;
    • Choi, Chang Min;
    • Kim, Mi‐Hyun;
    • Lee, Sung Yong;
    • Park, Cheol‐Kyu;
    • Chang, Yoon Soo;
    • Lee, Kye Young;
    • Kim, Seung Joon;
    • Yang, Sei Hoon;
    • Ryu, Jeong Seon;
    • Lee, Jeong Eun;
    • Lee, Shin Yup;
    • Park, Chan Kwon;
    • Lee, Sang Hoon;
    • Jang, Seung Hun;
    • Yoon, Seong Hoon
    Publication type:
    Article
    23
    24
    25
    26

    Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
    By:
    • Passaro, Antonio;
    • de Marinis, Filippo;
    • Tu, Hai-Yan;
    • Laktionov, Konstantin K.;
    • Feng, Jifeng;
    • Poltoratskiy, Artem;
    • Zhao, Jun;
    • Tan, Eng Huat;
    • Gottfried, Maya;
    • Lee, Victor;
    • Kowalski, Dariusz;
    • Yang, Cheng Ta;
    • Srinivasa, BJ;
    • Clementi, Laura;
    • Jalikop, Tejaswini;
    • Huang, Dennis Chin Lun;
    • Cseh, Agnieszka;
    • Park, Keunchil;
    • Wu, Yi-Long
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2018, v. 82, n. 6, p. 1031, doi. 10.1007/s00280-018-3694-5
    By:
    • Oda, Naohiro;
    • Hotta, Kastuyuki;
    • Ninomiya, Kiichiro;
    • Minami, Daisuke;
    • Ichihara, Eiki;
    • Murakami, Toshi;
    • Yokoyama, Toshihide;
    • Ichikawa, Hirohisa;
    • Chikamori, Kenichi;
    • Takigawa, Nagio;
    • Ochi, Nobuaki;
    • Harita, Shingo;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    46
    47
    48
    49
    50